Nov
27
2020

AcouSort approved for listing on Nasdaq First North Growth Market

AcouSort has on November 27, 2020, received approval for admission to trading on the Nasdaq First North Growth Market. The first day of trading on the Nasdaq First North Growth

Read More
Nov
25
2020

Interim Report Q3 2020

Regulatory

AcouSort publishes its interim report for the third quarter 2020. AcouSort 2020 Q3

Read More
Nov
10
2020

AcouSort gets two patent applications published

AcouSort has had two new patent applications published. The patents relate to improved methods for manipulating and separating specific cells, for example cancer cells in blood samples. Read the full

Read More
Oct
30
2020

AcouSort applies for listing on Nasdaq First North Growth Market

AcouSort has today applied to change trading venue to Nasdaq First North Growth Market. The company is currently listed on the Spotlight Stock Market, where the Company’s shares have been

Read More
Oct
30
2020

AcouSort receives order for AcouTrap from the University of Kentucky

AcouSort has received an order for an AcouTrap system from the University of Kentucky. The order is a direct effect of the evaluation of the system that the university launched

Read More
Oct
27
2020

AcouSort launches new project with Instrumentation Laboratory

Regulatory

Since 2015, AcouSort has worked with Instrumentation Laboratory (IL) on the integration of its technology in IL’s clinical analysis system. The new project aims to investigate whether AcouSort’s technology can

Read More
Oct
12
2020

AcouSort deltar på Investerarjakten

AcouSort kommer att delta i det livesända eventet Investerarjakten den 14 oktober. Bolagets vd Torsten Freltoft kommer att presentera utvecklingen under det gångna året samt planerna framåt. Presentationen inleds kl

Read More
Oct
2
2020

AcouSort initiates work on the Blue4Therapy project: The first step towards the stem cell treatment of the future

AcouSort has officially initiated the Blue4Therapy project. The aim of the project is to develop a platform for purification of patients’ own stem cells for further use in clinical applications

Read More
Sep
4
2020

AcouSort participates in a new important CAMP project

AcouSort will participate in yet another CAMP project. The goal is to develop a GMP-approved production of stem cells. Among other participants in the project are the Region Örebro län,

Read More
Aug
26
2020

Interim report Q2 2020

Regulatory

On August 26, AcouSort released its interim report for the second quarter of 2020. The report can be found in Swedish and English here: AcouSort Interim report Q2 2020. For all

Read More